slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 32,611-32,640
Pages 10,126
Rows per page 30
Component
32,611-32,640 of 303,780
19
Apollo Global Management | Mergers and Acquisitions Presentation Deck | 36 slidesApollo Global Management | Mergers and Acquisitions Presentation Deck | 36 slides · Apollo
Conference presentation Investment bank Beat · Evidence & Proof2 hits
24
Includes detailed footnotes explaining adjustments for transaction-related charges, performance fees, and Athene capital.Apollo Global Management | Mergers and Acquisitions Presentation Deck | 36 slides · Apollo
Conference presentation Investment bank 2 hits
01
Apollo Global Management | Mergers and Acquisitions Presentation Deck | 48 slidesApollo Global Management | Mergers and Acquisitions Presentation Deck | 48 slides · Apollo Global Management
Conference presentation Investment bank Beat · Situation & Context2 hits
04
The slide uses a top-down flow diagram to connect asset classes (Yield, Hybrid, Opportunistic) to distribution channels (Retirement Services, LPs, Public Vehicles, Capital Markets, Retail).Apollo Global Management | Mergers and Acquisitions Presentation Deck | 48 slides · Apollo Global Management
Conference presentation Investment bank Beat · Situation & Context2 hits
25
Apollo Global Management | Mergers and Acquisitions Presentation Deck | 48 slidesApollo Global Management | Mergers and Acquisitions Presentation Deck | 48 slides · Apollo Global Management
Conference presentation Investment bank Beat · Solution & ApproachLoop · Before After2 hits
40
The slide uses a numbered list format to structure the valuation arguments.Apollo Global Management | Mergers and Acquisitions Presentation Deck | 48 slides · Apollo Global Management
Conference presentation Investment bank Beat · Evidence & Proof2 hits
01
argenx SE | Results Presentation Deck | 20 slidesargenx SE | Results Presentation Deck | 20 slides · argenx
Conference presentation Investor relations Beat · Humble Origins2 hits
13
The slide compares CR and CRc rates for ITT and patients with >= 2 cycles, while noting 30-day mortality and adverse risk classification.argenx SE | Results Presentation Deck | 20 slides · argenx
Conference presentation Investor relations 2 hits
14
The diagram uses a hub-and-spoke model to represent the flow of innovation.argenx SE | Results Presentation Deck | 20 slides · argenx
Conference presentation Investor relations 2 hits
04
The slide uses a high-contrast table to contrast prevalence vs mortality across different disease states.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction2 hits
07
The slide uses color-coded regions on a world map with callout circles to summarize regional metrics.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
08
The slide uses a consistent visual language of bar charts with trend lines to communicate growth.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
10
The slide uses a three-column layout to present market data and strategic initiatives.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution2 hits
14
The slide uses a stacked bar chart to compare AstraZeneca (first bar) against five competitors (R, P, N, J, M).AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 2 hits
22
The slide uses a process flow at the top and a four-pillar framework at the bottom to explain the trial's methodology.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Loop · Hypothesis Test2 hits
23
The slide uses a color-coded grid to distinguish between highlighted pipeline assets and others, with extensive footnotes detailing specific drug mechanisms and disease targets.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 2 hits
25
AstraZeneca | Investor Day Presentation Deck | 86 slidesAstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 2 hits
26
The slide uses a Gantt-style chart to visualize the compression of development phases.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 2 hits
27
The slide uses a comparison structure between clinical trial data and real-world evidence.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 2 hits
29
The slide uses a three-column layout to present product features, scientific data, and clinical trial status.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 2 hits
32
The slide acts as a logistical guide for a multi-session virtual event.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 2 hits
34
CVRM stands for Cardiovascular, Renal and Metabolism.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 2 hits
37
Phase I SAD data presented with dose-response curves for 20mg, 30mg, 60mg, 90mg, and 120mg cohorts.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Beat · Market Size2 hits
38
Slide presents data from PROMIS observational trial and SATELLITE Phase IIa trial.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Beat · Market Size2 hits
39
The slide uses a three-panel structure to compare preclinical rodent models (left/center) with clinical trial data (right).AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Beat · Market Size2 hits
40
The slide combines a biological mechanism diagram with two bar charts showing clinical efficacy data.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Beat · Market Size2 hits
41
The slide uses color coding to distinguish between highlighted medicines and others in the pipeline.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Beat · Market Size2 hits
51
Includes references to specific clinical stages and therapeutic approaches (Farxiga, Lokelma, roxadustat).AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 2 hits
54
The slide uses a process-oriented layout to map drug development stages to a timeline of upcoming news events.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 2 hits
62
The slide uses a three-column layout to present quantitative data points for each disease category, supported by footnotes.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 2 hits